₵1,313.00
60 Boundary Road,
American House East Legon.
Accra - Ghana
0256774751 / 0506608330
Patient One MediLean supplies a synergistic combination of three clinically supported ingredients—Meratrim®, Capsimax™ and chromium picolinate—in a convenient 1 capsule dose. This multi-functional formula supports lean muscle mass and reduced body fat by promoting lipolysis (fat breakdown) from improved adiponectin levels, thermogenesis (fat burning), and insulin-modulating activity. The natural ingredients in MediLean promote healthy weight management without the use of stimulants.*
Chromium Picolinate is an essential mineral providing chromium that is bound to picolinic acid, which facilitates its absorption. In a study, chromium picolinate supplementation helped reduce carbohydrate intake and mood fluctuations. Studies suggest chromium helps maintain already normal glucose levels and insulin sensitivity.*
Meratrim® is a unique ingredient made with a proprietary blend of extracts from Sphaeranthus indicus flower heads and Garcinia mangostana fruit rind.
Meratrim® demonstrated positive weight management outcomes in three randomized, double-blind, placebo-controlled human clinical studies. An 800 mg daily dose of this ingredient resulted in statistically significant reductions in body weight, BMI, waist and hip circumference that exceeded those achieved via diet and exercise alone. The botanical blend’s effect on body weight and body composition parameters occurred as early as 2 weeks and continued to increase during an 8-week trial.*
Adults 18 and older take 1 capsule with breakfast and 1 capsule with dinner, or as directed by your health practitioner. Do not take on an empty stomach. Store in a cool, dry place.
If you are pregnant, nursing, or taking any medications, consult your healthcare practitioner before use. Discontinue use and consult your healthcare practitioner if any adverse reactions occur. Keep out of reach of children. Use only if safety seal is intact.
Sign in to your account
Reviews
There are no reviews yet.